| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 92,015 | 92,821 |
| Effect of exchange rate changes on cash and cash equivalents | 27 | 38 |
| Net decrease in cash and cash equivalents | -103,756 | -18,350 |
| Cash and cash equivalents at beginning of period | 163,962 | - |
| Cash and cash equivalents at end of period | 60,206 | - |
Cabaletta Bio, Inc. (CABA)
Cabaletta Bio, Inc. (CABA)